Liver Tumor Ablation: Types, Procedure, Benefits and Risks

Liver tumor ablation treatment involves destroying cancerous or metastatic liver lesions using localized thermal or freezing energy. This method provides an alternative for patients not suitable for surgical resection.

Techniques such as radiofrequency ablation, microwave ablation, and cryoablation are performed under ultrasound or CT guidance. These ensure accurate targeting and minimize damage to surrounding healthy liver tissue.

The procedure offers significant benefits, including reduced hospitalization, minimal invasiveness, and repeatability. It is frequently applied in hepatocellular carcinoma and metastatic colorectal cancer cases.

Indications include patients with unresectable liver tumors, poor surgical candidates, or those requiring bridge therapy before transplantation. Liver ablation provides effective local control and improved survival outcomes.

Table of Content

What Is Liver Tumor Ablation Therapy?

Liver tumor ablation therapy is especially applied to tumors that are inaccessible or risky for surgery. This method targets tumor tissue to destroy cancer cells. It preserves the patient’s overall health and offers a faster recovery. There are various techniques for liver tumor ablation therapy:

Radiofrequency Ablation (RFA): Destroys cancer cells with high‑energy radio waves.
Microwave Ablation (MWA): Inactivates the tumor by heating it with microwaves.
Cryoablation: Freezes tumor cells to halt their function.
Chemical Ablation: Injects chemicals such as ethanol directly into the tumor to destroy cancer cells.
Irreversible Electroporation (IRE): Creates pores in the cell membrane with electric pulses.

These treatment methods are selected based on the patient’s condition and tumor characteristics.

How Is Liver Tumor Ablation Therapy Performed?

This treatment is performed using minimally invasive techniques, accelerating the patient’s recovery. During the procedure, doctors use modern imaging technologies to locate the tumor precisely. The procedure includes the following steps:

First, imaging methods such as CT or ultrasound are used to determine the tumor’s location.

Next, a special needle is guided from the skin surface into the liver tissue.

Once the needle reaches the tumor cells, one of the following ablation techniques is applied:

Radiofrequency Ablation: A high‑frequency electric current is sent through an electrode, heating and destroying the tumor.
Microwave Ablation: Focused microwave energy is applied via an antenna to heat and destroy tumor cells.
Local anesthesia is administered to the skin, and deep sedation or analgesia is provided to manage pain during heating. General anesthesia may rarely be needed.
Cryoablation: Tumor cells are frozen and destroyed with cryogenic gas.

What Is the Post‑Treatment Process?

The post‑treatment process for liver tumor ablation includes several important steps for patients to follow. Pain may occur in the abdominal area after the procedure, but it usually subsides quickly. Doctor‑prescribed pain relievers provide relief during this period.

Pain Management: Use prescribed pain relievers as recommended by your doctor.
Rest: Rest your body and avoid strenuous activities for a few days after the procedure.
Wound Care: Keep the incision site dry and clean to minimize infection risk.
Nutrition: Maintain a balanced, healthy diet. Focus on liquid foods during the first days.
Exercise: Perform light exercises recommended by your doctor to support recovery.
Follow‑up: Attend regular doctor visits to monitor your recovery.

If any new symptoms or concerns arise, contact your healthcare provider without delay.

What Are the Advantages of Liver Tumor Ablation Therapy?

Ablation therapy offers many advantages in liver cancer treatment. Its minimally invasive nature makes this treatment stand out. Compared to surgical intervention, this method carries fewer complication risks for patients. Patients can recover more quickly after treatment. These features significantly improve patient comfort.

Minimal Invasiveness: No open surgery is needed, resulting in less pain and shorter hospital stays.
High Success Rate: Highly effective for early‑stage liver cancer. Success rates are high depending on cancer stage and size.
Short Hospital Stay: Patients are usually discharged quickly, enabling a faster return to normal life.
Repeatability: Ablation can be repeated if cancer recurs, which is a major advantage.
Fewer Side Effects: Causes fewer side effects than chemotherapy and radiation, supporting rapid recovery.
Prevents Cancer Spread: Helps prevent the spread of cancer cells to other organs, aiding disease control.

The effectiveness of this treatment option varies according to each patient’s condition and tumor characteristics. However, liver tumor ablation therapy is generally recognized as a strong and effective method in the fight against cancer, offering a safe and low‑complication alternative for patients.

Frequently Asked Questions

How is ablation therapy performed for liver tumors?

Ablation therapy for liver tumors is performed using minimally invasive techniques such as radiofrequency ablation (RFA) and microwave ablation (MWA) to destroy cancerous tissue. RFA generates heat with high‑frequency electric currents, while MWA uses electromagnetic microwaves. These procedures are typically guided by ultrasound or CT and can be performed percutaneously, laparoscopically, or during open surgery. Ablation is preferred for patients with early‑stage hepatocellular carcinoma (HCC) or metastatic liver tumors who are not suitable for surgical resection. The choice between RFA and MWA depends on factors such as tumor size (MWA is generally preferred for tumors ≥ 3 cm), location, and proximity to blood vessels. MWA offers higher intratumoral temperatures and faster ablation times, making it advantageous for larger tumors or those near major vessels. Both methods aim to achieve complete tumor necrosis with a ≥ 10 mm safety margin to minimize local recurrence. The procedures are generally well tolerated, have low complication rates, and can be repeated if necessary. However, the efficacy of ablation therapy depends on tumor characteristics and the medical team’s experience.

What are the differences between radiofrequency ablation and microwave ablation?

Radiofrequency ablation (RFA) and microwave ablation (MWA) are minimally invasive treatments for liver tumors with distinct differences. RFA uses alternating current to generate heat and cause cell death via thermal coagulation necrosis, while MWA uses electromagnetic microwaves to achieve higher intratumoral temperatures and larger ablation zones. MWA provides faster ablation times and is less affected by the heat‑sink effect near blood vessels. Clinical studies show that RFA and MWA have similar overall survival and local recurrence rates for hepatocellular carcinoma (HCC). However, MWA is generally more effective for larger tumors or lesions near major vessels. MWA also allows the use of multiple probes simultaneously, enabling treatment of multiple lesions and increasing procedural efficiency. While both techniques are effective, MWA’s technical advantages make it preferable in certain clinical scenarios.

Can tumors recur after ablation therapy?

Yes, liver tumors can recur after ablative therapy. The 1‑year disease‑free survival rate after microwave ablation (MWA) is approximately 80.2%, decreasing to 70.3% at 3 years. Factors that increase recurrence risk include tumor size, inadequate ablation margins, multiple lesions, and Child–Pugh B liver function. Tumor location and high alpha‑fetoprotein levels also affect recurrence rates. Regular follow‑up is essential for early detection and treatment of recurrences.

Do patients feel pain during this treatment?

Patients may experience varying levels of pain during liver tumor ablation. One study reported that 42.7% of patients undergoing percutaneous thermal liver ablation experienced post‑procedural pain rated 4 or higher. Factors such as female gender, anxiety or depression, and chronic pain history were associated with higher pain levels. Women reported higher average maximum pain scores (3.88 vs. 2.73) and required more analgesics in the recovery room. Oxycodone provided better pain control and fewer side effects than fentanyl during percutaneous radiofrequency ablation. Regional anesthesia techniques, such as hepatic hilar nerve block, have also been effective for pain management. Therefore, personalized pain management during and after treatment is important.

For what tumor sizes is ablation therapy effective?

Liver tumor ablation therapy is especially effective for hepatocellular carcinoma (HCC) tumors smaller than 3 cm, providing survival rates comparable to surgical resection. For tumors between 3 and 5 cm, treatment efficacy decreases, local recurrence rates increase, and survival rates are lower compared to surgery. Studies have shown significantly higher overall and cancer‑specific mortality rates after ablation for 3–5 cm tumors compared to surgery. Therefore, ablation is generally recommended for tumors up to 3 cm, while larger tumors may benefit more from surgical intervention.

Prof. Dr. Özgür KILIÇKESMEZ

Prof. Dr. Özgür Kılıçkesmez is one of Türkiye’s leading interventional radiology and neuroradiology specialists, focusing on minimally invasive endovascular treatments. His primary areas of expertise include aneurysm and stroke treatments, embolization procedures, non-surgical treatments of thyroid and parathyroid diseases, interventional oncology, and peripheral vascular interventions. He currently serves as the Head of the Interventional Radiology and Neuroradiology Department at Istanbul Memorial Göztepe Hospital.
Graduating from Istanbul University Cerrahpaşa Faculty of Medicine in 1997, Prof. Dr. Kılıçkesmez received advanced training in interventional radiology and oncology as a Clinical Fellow at London Guy’s & St Thomas’ and King’s College Hospital between 2012 and 2013. He earned the title of Professor in 2020 and, in the same year, became the Founding Interventional Radiologist at SBÜ Çam and Sakura City Hospital. He also holds the EBIR (European Board of Interventional Radiology) certification.
Prof. Dr. Kılıçkesmez has 94 international and 40 national publications and over 2500 citations. He serves as a reviewer for prestigious journals such as the American Journal of Roentgenology (AJR) and Diagnostic & Interventional Radiology. With his clinical and academic expertise, he is a nationally and internationally recognized authority in stroke treatment, brain aneurysm, embolization, tumor ablation, and minimally invasive treatments of thyroid/parathyroid diseases.